The neglected issue of cardiac amyloidosis in trials on heart failure with preserved ejection fraction in the elderly

2020 ◽  
Vol 22 (9) ◽  
pp. 1740-1741 ◽  
Author(s):  
Domitilla Russo ◽  
Maria Beatrice Musumeci ◽  
Massimo Volpe
2010 ◽  
Vol 6 (2) ◽  
pp. 33 ◽  
Author(s):  
Christopher R deFilippi ◽  
G Michael Felker ◽  
◽  

For many with heart failure, including the elderly and those with a preserved ejection fraction, both risk stratification and treatment are challenging. For these large populations and others there is increasing recognition of the role of cardiac fibrosis in the pathophysiology of heart failure. Galectin-3 is a novel biomarker of fibrosis and cardiac remodelling that represents an intriguing link between inflammation and fibrosis. In this article we review the biology of galectin-3, recent clinical research and its application in the management of heart failure patients.


2019 ◽  
Vol 25 (8) ◽  
pp. S53
Author(s):  
Virginia S. Hahn ◽  
Wendy Ying ◽  
Yi Zhen Joan Lee ◽  
Lisa R. Yanek ◽  
Dhananjay Vaidya ◽  
...  

2020 ◽  
Vol 75 (11) ◽  
pp. 691
Author(s):  
Omar Farid Abou-Ezzeddine ◽  
Daniel Davies ◽  
Jasmine A. Sexton ◽  
Christopher G. Scott ◽  
Ahmed Fayyaz ◽  
...  

2016 ◽  
Vol 22 (7) ◽  
pp. 539-544 ◽  
Author(s):  
Michael Fu ◽  
Jingmin Zhou ◽  
Erik Thunström ◽  
Torbjörn Almgren ◽  
Ludger Grote ◽  
...  

Author(s):  
Emna Allouche ◽  
Habib Ben Ahmed ◽  
Wejdène Ouechtati ◽  
Mariem Jabeur ◽  
Slim Sidhom ◽  
...  

Author(s):  
Evandro Tinoco Mesquita ◽  
Antonio José Lagoeiro Jorge ◽  
Celso Vale Souza Junior ◽  
Thais Ribeiro de Andrade

Sign in / Sign up

Export Citation Format

Share Document